Publication | Closed Access
MA13.08 CHOICE-01: A Phase 3 Study of Toripalimab Versus Placebo in Combination With First-Line Chemotherapy for Advanced NSCLC
11
Citations
0
References
2021
Year
Advanced NsclcOncologyPharmacologyToripalimab Versus PlaceboPharmacotherapyAnti-cancer AgentMa13.08 Choice-01Cancer TreatmentMedicineLung Cancer
No additional data available for this publication yet. Check back later!